These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11142479)
21. Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study. Iannitti D; Dipetrillo T; Akerman P; Barnett JM; Maia-Acuna C; Cruff D; Miner T; Martel D; Cioffi W; Remis M; Kennedy T; Safran H Am J Clin Oncol; 2005 Dec; 28(6):570-5. PubMed ID: 16317266 [TBL] [Abstract][Full Text] [Related]
22. Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer. Wilkowski R; Thoma M; Bruns C; Wagner A; Heinemann V JOP; 2006 Jul; 7(4):349-60. PubMed ID: 16832132 [TBL] [Abstract][Full Text] [Related]
23. Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. Heinemann V; Quietzsch D; Gieseler F; Gonnermann M; Schönekäs H; Rost A; Neuhaus H; Haag C; Clemens M; Heinrich B; Vehling-Kaiser U; Fuchs M; Fleckenstein D; Gesierich W; Uthgenannt D; Einsele H; Holstege A; Hinke A; Schalhorn A; Wilkowski R J Clin Oncol; 2006 Aug; 24(24):3946-52. PubMed ID: 16921047 [TBL] [Abstract][Full Text] [Related]
24. Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study. Kakolyris S; Papadakis E; Tsiafaki X; Kalofonos C; Rapti A; Toubis M; Bania E; Kouroussis C; Chainis K; Androulakis N; Agelaki S; Sarra E; Vardakis N; Georgoulias V; Lung Cancer; 2001 May; 32(2):179-87. PubMed ID: 11325489 [TBL] [Abstract][Full Text] [Related]
25. Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension. He J; Ying W; Yang H; Xu X; Shao W; Guan Y; Jiang M; Wu Y; Zhong B; Wang D; Tucker S; Zhong N Anticancer Drugs; 2009 Oct; 20(9):838-44. PubMed ID: 19668080 [TBL] [Abstract][Full Text] [Related]
27. [A phase II study of combination chemotherapy with gemcitabine, 5-fluorouracil, and cisplatin for advanced pancreatic cancer]. Choi SB; Lee HY; Yuh YJ; Kim SR Korean J Gastroenterol; 2005 May; 45(5):348-53. PubMed ID: 15908768 [TBL] [Abstract][Full Text] [Related]
28. Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer. ten Bokkel Huinink WW; Bergman B; Chemaissani A; Dornoff W; Drings P; Kellokumpu-Lehtinen PL; Liippo K; Mattson K; von Pawel J; Ricci S; Sederholm C; Stahel RA; Wagenius G; Walree NV; Manegold C Lung Cancer; 1999 Nov; 26(2):85-94. PubMed ID: 10568679 [TBL] [Abstract][Full Text] [Related]
29. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V; Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442 [TBL] [Abstract][Full Text] [Related]
31. Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. Colucci G; Labianca R; Di Costanzo F; Gebbia V; Cartenì G; Massidda B; Dapretto E; Manzione L; Piazza E; Sannicolò M; Ciaparrone M; Cavanna L; Giuliani F; Maiello E; Testa A; Pederzoli P; Falconi M; Gallo C; Di Maio M; Perrone F; ; ; J Clin Oncol; 2010 Apr; 28(10):1645-51. PubMed ID: 20194854 [TBL] [Abstract][Full Text] [Related]
32. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma. Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224 [TBL] [Abstract][Full Text] [Related]
33. Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Cascinu S; Labianca R; Catalano V; Barni S; Ferraù F; Beretta GD; Frontini L; Foa P; Pancera G; Priolo D; Graziano F; Mare M; Catalano G Ann Oncol; 2003 Feb; 14(2):205-8. PubMed ID: 12562645 [TBL] [Abstract][Full Text] [Related]
34. FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience. Chllamma MK; Cook N; Dhani NC; Giby K; Dodd A; Wang L; Hedley DW; Moore MJ; Knox JJ Br J Cancer; 2016 Sep; 115(6):649-54. PubMed ID: 27467054 [TBL] [Abstract][Full Text] [Related]
35. Phase II study of gemcitabine plus cisplatin in metastatic breast cancer. Fuentes H; Calderillo G; Alexander F; Ramirez M; Avila E; Perez L; Aguirre G; Oñate-Ocaña LF; Gallardo D; Otero J Anticancer Drugs; 2006 Jun; 17(5):565-70. PubMed ID: 16702814 [TBL] [Abstract][Full Text] [Related]
36. Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study. Bauknecht T; Hefti A; Morack G; Villena-Heinsen C; Wallwiener D; Elling D; Minckwitz GV; Mansouri K; Blatter J; Breitbach GP Int J Gynecol Cancer; 2003; 13(2):130-7. PubMed ID: 12657112 [TBL] [Abstract][Full Text] [Related]
37. Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer. Kroep JR; Pinedo HM; Giaccone G; Van Bochove A; Peters GJ; Van Groeningen CJ Ann Oncol; 2004 Feb; 15(2):230-5. PubMed ID: 14760114 [TBL] [Abstract][Full Text] [Related]
38. Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? Stemmler J; Stieber P; Szymala AM; Schalhorn A; Schermuly MM; Wilkowski R; Helmberger T; Lamerz R; Stoffregen C; Niebler K; Garbrecht M; Heinemann V Onkologie; 2003 Oct; 26(5):462-7. PubMed ID: 14605463 [TBL] [Abstract][Full Text] [Related]
39. Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study. Belpomme D; Krakowski I; Beauduin M; Petit T; Canon JL; Janssens J; Gauthier S; De Pauw A; Moreau V; Kayitalire L Gynecol Oncol; 2003 Oct; 91(1):32-8. PubMed ID: 14529659 [TBL] [Abstract][Full Text] [Related]
40. [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]. Barhoumi M; Mornex F; Bonnetain F; Rougier P; Mariette C; Bouché O; Bosset JF; Aparicio T; Mineur L; Azzedine A; Hammel P; Butel J; Stremsdoerfer N; Maingon P; Bedenne L; Chauffert B Cancer Radiother; 2011 Jun; 15(3):182-91. PubMed ID: 21315644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]